|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,750 KRW | +0.30% |
|
+2.58% | -9.15% |
Kwang Dong Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was KRW 1,886.23 million compared to KRW 3,111.91 million a year ago. Net income was KRW 18,200.04 million compared to KRW 14,044.36 million a year ago.
Basic earnings per share from continuing operations was KRW 454 compared to KRW 342 a year ago. Basic earnings per share was KRW 454 compared to KRW 342 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.15% | 195M | |
| +20.37% | 43.54B | |
| +18.30% | 21.78B | |
| +18.37% | 15.38B | |
| +25.55% | 15.12B | |
| +60.99% | 13.36B | |
| -0.05% | 6.79B | |
| -14.84% | 6.38B | |
| -8.87% | 5.73B | |
| +8.17% | 5.32B |
KWANG DONG PHARMACEUTICAL CO., LTD. 
